New oral weight loss drug enters human testing
NCT ID NCT07239973
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tests an experimental weight loss pill called BGM0504 in 75 healthy and overweight or obese Chinese adults. Participants will receive either the drug or a placebo to check for side effects and measure weight changes over 8 weeks. The goal is to see if the drug is safe enough for further study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BGM0504 tablets
- What this could lead to
- If successful, this could lead to a new oral medication for weight management in overweight or obese individuals.
- What could go wrong
- This is an early Phase 1 trial with only 75 participants, focused on safety. It is too small and early to know if the drug works or is safe long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Yunnan University of Chinese Medicine
RECRUITINGKunming, Yunnan, 650000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test